Skip to main content

Table 1 Baseline and ongoing data collection

From: Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease

Baseline data

age, sex, ethnicity, height, target weight, waist circumference

 

dialysis start date, cause of ESKD

 

type of dialysis access

 

medication use

 

comorbidities

 

hemoglobin, albumin, Kt/V, urea reduction ratio, lipid profile

 

calcium, phosphate, PTH, alkaline phosphatase

 

vitamin K status (phylloquinone, PIVKA-II, osteocalcin)

Monthly data

Hemoglobin, albumin, Kt/V, urea reduction ratio

 

Calcium, phosphate

 

Hospitalizations

 

Cardiovascular events and procedures

 

Medication use

 

Adherence

Q3 monthly laboratory data

PTH, alkaline phosphatase, lipid profile

Q4 monthly laboratory data

Vitamin K status (phylloquinone, PIVKA-II, osteocalcin)